Ignite Creation Date:
2024-05-06 @ 12:53 PM
Last Modification Date:
2024-10-26 @ 1:05 PM
Study NCT ID:
NCT03876587
Status:
UNKNOWN
Last Update Posted:
2019-03-15
First Post:
2019-03-11
Brief Title:
Pyrotinib Combined With Docetaxel in the First-line Treatment of HER2-positive MBC
Sponsor:
Zhejiang Cancer Hospital
Organization:
Zhejiang Cancer Hospital